Abstract

Summary

Blocking orexin receptors (OX1R and OX2R) in the retina significantly alters expression of key circadian clock genes in both the retina and hypothalamus, suggesting that retinal orexin signaling plays an important modulatory role in synchronizing peripheral and central biological clocks. These findings open potential new therapeutic targets for circadian rhythm disorders and conditions linked to circadian dysfunction, including sleep disorders and neurodegenerative diseases like Alzheimer's.
Abstract

Key Findings

  • Intravitreal injection of OX1R antagonist (SB-334867) and OX2R antagonist (JNJ-10397049) significantly up-regulated C-fos expression in the retina at multiple zeitgeber time points (ZT 3, 6, 12, 24).
  • Combined blockade of OX1R and OX2R produced a greater increase in retinal C-fos expression than either antagonist alone.
  • Hypothalamic VIP and PACAP expression was significantly up-regulated following both OX1R and OX2R antagonist treatment.
  • Hypothalamic and retinal Bmal1 expression was significantly down-regulated in antagonist-treated groups.
  • Hypothalamic C-fos expression was down-regulated across all antagonist-treated groups, indicating disrupted SCN activity rhythmicity.
Categories

Categories

Sleep & Circadian Health: Retinal orexin receptor blockade disrupts circadian gene expression (Bmal1, C-fos, VIP, PACAP) in both retina and SCN/hypothalamus, linking peripheral and central clock regulation.
The Science of Light: Demonstrates a novel retinal orexin signaling pathway that modulates retinohypothalamic tract communication and hypothalamic rhythmicity, expanding understanding of non-photoreceptor photic signal processing.
Dementia & Elder Care: Authors suggest findings may inform understanding of circadian disruption in neurodegenerative disorders such as Alzheimer's disease.
Authors

Author(s)

M Haddad, H Khazali, M Janahmadi, H Ghanbarian
Publication Date

Publication Year

2023
View more publications